News
Block (XYZ) Surpasses Q2 Earnings Estimates
Block (XYZ) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.93 per share a year ago. These figures are
Why the Market Dipped But Micron (MU) Gained Today
In the latest close session, Micron (MU) was up +2.84% at $111.87. The stock outpaced the S&P 500's daily loss of 0.08%. At the same time, the Dow lost 0.51%, and the tech-heavy Nasdaq gained 0.35%
Figs (FIGS) Q2 Earnings and Revenues Beat Estimates
Figs (FIGS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago. These figures are
Federal Agricultural Mortgage (AGM) Q2 Earnings and Revenues Top Estimates
Federal Agricultural Mortgage (AGM) came out with quarterly earnings of $4.32 per share, beating the Zacks Consensus Estimate of $4.29 per share. This compares to earnings of $3.63 per share a year
Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.4 per share a year ago
Workday (WDAY) Registers a Bigger Fall Than the Market: Important Facts to Note
Workday (WDAY) closed the most recent trading day at $220.98, moving -3.54% from the previous trading session. This change lagged the S&P 500's daily loss of 0.08%. On the other hand, the Dow
Atlassian (TEAM) Q4 Earnings and Revenues Top Estimates
Atlassian (TEAM) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.66 per share a year ago. These figures
TerrAscend Corp. (TSNDF) Reports Q2 Loss, Beats Revenue Estimates
TerrAscend Corp. (TSNDF) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago. These
Wynn Resorts (WYNN) Q2 Earnings and Revenues Miss Estimates
Wynn Resorts (WYNN) came out with quarterly earnings of $1.09 per share, missing the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.12 per share a year ago. These
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates
Sangamo Therapeutics (SGMO) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago. These
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.07 per share a year ago. These figures
Motorola (MSI) Tops Q2 Earnings and Revenue Estimates
Motorola (MSI) came out with quarterly earnings of $3.57 per share, beating the Zacks Consensus Estimate of $3.36 per share. This compares to earnings of $3.24 per share a year ago. These figures
The Manitowoc Company, Inc. (MTW) Misses Q2 Earnings and Revenue Estimates
The Manitowoc Company, Inc. (MTW) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.25 per share a year
Lionsgate Studios Corp. (LION) Reports Q1 Loss, Misses Revenue Estimates
Lionsgate Studios Corp. (LION) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.01 per share a year ago. These
Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates
Gilead Sciences (GILD) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $2.01 per share a year ago. These
VAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue Estimates
VAREX IMAGING (VREX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.14 per share a year ago. These
10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates
10x Genomics (TXG) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of a loss of $0.35 per share. This compares to a loss of $0.32 per share a year ago
Genpact (G) Surpasses Q2 Earnings and Revenue Estimates
Genpact (G) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.79 per share a year ago. These figures are
Pinterest (PINS) Misses Q2 Earnings Estimates
Pinterest (PINS) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.29 per share a year ago. These figures
Microchip Technology (MCHP) Q1 Earnings and Revenues Surpass Estimates
Microchip Technology (MCHP) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.53 per share a year ago
Erie Indemnity (ERIE) Misses Q2 Earnings and Revenue Estimates
Erie Indemnity (ERIE) came out with quarterly earnings of $3.34 per share, missing the Zacks Consensus Estimate of $3.55 per share. This compares to earnings of $3.13 per share a year ago. These
Applied Optoelectronics (AAOI) Reports Q2 Loss, Misses Revenue Estimates
Applied Optoelectronics (AAOI) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.28 per share a year ago. These
Do Options Traders Know Something About BancFirst Stock We Don't?
Investors in BancFirst Corporation BANF need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $60 Put had some of the highest
Implied Volatility Surging for BankFinancial Stock Options
Investors in BankFinancial Corporation BFIN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $10 Call had some of the highest
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
Nektar Therapeutics (NKTR) came out with a quarterly loss of $2.95 per share versus the Zacks Consensus Estimate of a loss of $3.13. This compares to a loss of $3.75 per share a year ago. These


